BerGenBio ASA (OSL:BGBIO)
Norway · Delayed Price · Currency is NOK 1.148
-0.002 (-0.17%)
Aug 15, 2025, 4:19 PM CET
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 44.87 million as of August 15, 2025. Its market cap has decreased by -90.96% in one year.
Market Cap
44.87M
Enterprise Value
-94.02M
Revenue
848.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 1.24B to 44.87M, a decrease of -96.39%. That is a compound annual growth rate of -32.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 44.87M | -85.97% |
| Dec 30, 2024 | 319.77M | -57.22% |
| Dec 29, 2023 | 747.46M | 12.86% |
| Dec 30, 2022 | 662.29M | -63.08% |
| Dec 30, 2021 | 1.79B | -36.16% |
| Dec 30, 2020 | 2.81B | 88.93% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.11B |
| Nordhealth AS | 2.96B |
| Photocure ASA | 1.64B |
| ArcticZymes Technologies ASA | 1.29B |
| Vistin Pharma ASA | 1.07B |
| Omda AS | 1.02B |
| Gentian Diagnostics ASA | 894.50M |
| Thor Medical ASA | 845.40M |